Bioprocessing Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Scale of Operation, Process, Application, End User, and Geography

Description

List of Tables

The bioprocessing market size is projected to surge from US$ 25.35 billion in 2023 to US$ 75.55 billion by 2031; the market is estimated to record a CAGR of 14.0% during 2023-2031. The increasing prevalence of chronic diseases and the growing biopharmaceutical industry propel the bioprocessing market growth.

Bioprocessing increases the number of living cells or other biological systems/components (such as bacteria, enzymes, proteins, viruses, or nucleic acids) in a commercial bioreactor for biopharmaceutical manufacturing. Products produced in the bioprocessing sector typically contain high-quality therapeutics and vaccines critical to modern healthcare advancement. The current bioprocessing industry landscape is characterized by dynamic developments driven by advances in biotechnology and increasing demand for biopharmaceuticals. The increase in demand is attributed to the prevalence of chronic diseases, the growing adoption of personalized medicine, and increasing bioprocessing applications in various sectors. As bioprocessing becomes significantly important in producing therapeutic proteins, vaccines, and other bio-based products, it turns out to be a key enabler of the biotechnological revolution. The market is progressing toward meeting the demands of a changing healthcare landscape, and the need for efficient and scalable bioproduction processes is expected to bring new bioprocessing market trends in the coming years.

Growing Biopharmaceutical Industry Drives the Bioprocessing Market

In the biopharmaceutical industry, improved bioprocesses are always in demand to address new regulatory requirements, quality control requirements, and production issues in biological products, cell culture titration, and biosimilar production. In recent years, the biopharmaceutical industry has been growing at an unprecedented pace. Biopharmaceutical companies are spending huge sums in R&D to introduce new molecules with enhanced medical and commercial potency for various therapeutic applications. The acceptance of bioprocessing is gradually increasing due to its wide application in research, development, and manufacturing of biologics and biosimilars. Big pharmaceutical companies and contract research organizations are coming up with new medicines and therapy forms to treat a wide range of indications. Further, a strong demand for biologics and biosimilars to treat chronic diseases is, in turn, driving the growth of the biopharmaceutical industry. The biopharmaceutical industry is one of the most significant contributors to the economy. The US is the largest market for biopharmaceuticals and the leader in biopharmaceutical R&D. As per the Pharmaceutical Research and Manufacturers Association, the US firms conduct over half the world's R&D in pharmaceuticals (US$ 75 billion) and hold the highest number of patents in new medicines. Besides growing economies, rapid growth is witnessed in the research environment in emerging economies such as Brazil, China, and India. Factors such as increasing biologics approval, growing biosimilar pipeline, rising investment in research activities, and increasing focus on developing affordable biologics are facilitating the growth of the biopharmaceutical industry.

Apart from these, increasing approvals in gene and cell therapies are favoring the bioprocessing market growth. The approved gene therapies are Glybera (to treat lipoprotein lipase deficiency) and Strimvelis (to treat ADA-severe combined immunodeficiency). Thus, the factors mentioned above are increasing the demand for the large-scale production of various therapeutics, thereby facilitating the growth of the bioprocessing market globally.

Market Trend

Shift Toward Automated Cell Therapy Manufacturing

A rising number of cell therapies have shifted the production of cell therapy products from a small volume to a large volume worldwide. Increasing research activities in cell therapies have led to a rise in the demand for advanced manufacturing solutions. In view of this, many players are offering products to meet the needs of academic researchers and large biotechnology companies. For instance, the Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are designed to enable the automation of most sequential unit operations for a CAR-T process within a single system. In addition, the evolution of cell therapy-from an academic and clinical setting to mass production and commercialization-is increasing the demand for automation in manufacturing. In May 2019, GE Healthcare launched the Chronicle web application to support the complete cell therapy workflow. Chronicle automation software is a good manufacturing practice-compliant digital solution designed to optimize complex cell therapy process development and manufacturing. Companies are also entering into strategic and technological developments for automation in cell therapy. For instance, in July 2020, Thermo Fisher Scientific Inc. and Lyell Immunopharma partnered to develop and manufacture processes to design effective cell therapies for cancer patients. Under this partnership, the companies aim to improve the fitness of T-cells and support the development of an integrated cGMP-compliant platform (system and software) along with reagents, consumables, and instruments. In March 2019, Lonza partnered with Israel's Sheba Medical Center to provide automated and closed CAR-T manufacturing using its point-of-care Cocoon cell therapy manufacturing platform.

Automated procedures can drastically reduce the production cost and enhance staff productivity and retention rates. Other than these factors, automated processes restrict various possible sources of contamination in the manufacturing unit and eventually enhance process consistency, which results in overall good quality products by reducing manual errors. Thus, the increasing adoption of automation among cell therapy manufacturers and the growing product innovations in the field of cell therapy are likely to boost cell therapy bioprocessing or manufacturing.

The "Global Bioprocessing Market" is segmented on the basis of product, scale of operation, process, application, end user, and geography.

Product-Based Insights

Based on product type, the bioprocessing market is segmented into instruments, and consumables and accessories. The instruments segment held a larger market share in 2023 and is anticipated to register a higher CAGR of 14.5% during the forecast period. The instruments segment includes chromatography systems, filtration devices, osmometers, incubators, centrifuges, drying devices, and bioreactors. From pilot to process scale, chromatography systems are intended to provide persistent performance with processing flexibility as per the client's requirement. Sartorius AG offers Resolute BioSC Pilot Multi-Column Chromatography Systems-configurable automated systems with scalability that boost comprehensive support in pre- and post-sales. Ongoing advancements in bioreactor designs have led to the development of sophisticated systems capable of accommodating a range of cell types, from mammalian and microbial cells to plant and insect cells. Moreover, the use of single-use and flexible bioreactor technologies has gained prominence, offering scalability, flexibility, and reduced contamination risks. Advances in filtration technologies have led to the development of advanced filter media, such as depth filters, membrane filters, and chromatographic resins, offering enhanced capture efficiency, scalability, and purity for bioprocessing applications.

Process-Based Insights

Based on process, the bioprocessing market is segmented into downstream bioprocess and upstream bioprocess. The downstream bioprocess segment dominated the bioprocessing market share in 2023 and is anticipated to register a higher CAGR of 14.4% during the forecast period. The upstream bioprocess accounted for 31.2% of the market share. Upstream bioprocessing is critical for the product's success, as it sets the foundation for the quality and quantity of the resultant product. Upstream bioprocessing points toward the initial stages of the production process in which microbes, cells, and bacteria are grown, nurtured, and developed through various technologies and media. These steps are complex and challenging, as high control is required over cell cultures and the environment in which cells are grown. The stages of upstream bioprocessing are cell isolation, cultivation, cell banking, and culture expansion. Furthermore, it is anticipated that technologies such as artificial intelligence and machine learning will be essential in upstream bioprocessing.

US Food and Drug Administration, Global Cancer Observatory, World Health Organization, Organization for Economic Co-operation and Development, National Human Genome Research Institute, International Trade Administration, and Pharmaceutical Research and Manufacturers Association are some of the relevant sources referred while preparing the bioprocessing market research report.

Product Code: TIPRE00039016

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Bioprocessing Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Bioprocessing Market - Key Market Dynamics

5.1 Bioprocessing Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Chronic Diseases
- 5.2.2 Growing Biopharmaceutical Industry
5.3 Market Restraints
- 5.3.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.4 Market Opportunities
- 5.4.1 Proliferating Demand for Personalized Medicine
5.5 Future Trends
- 5.5.1 Shift Toward Automated Cell Therapy Manufacturing
5.6 Impact of Drivers and Restraints:

6. Bioprocessing Market - Global Market Analysis

6.1 Bioprocessing Market Revenue (US$ Million), 2023-2031

7. Bioprocessing Market Analysis - by Product

7.1 Overview
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031(US$ Million) - By Instruments
    - 7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031(US$ Million) - By Bioreactors
    - 7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031(US$ Million) - By Chromatography Systems
7.3 Consumables and Accessories
- 7.3.1 Overview
- 7.3.2 Consumables and Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031(US$ Million) - By Consumables and Accessories

8. Bioprocessing Market Analysis - by Scale Of Operation

8.1 Overview
8.2 Commercial Operations
- 8.2.1 Overview
- 8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
- 8.3.1 Overview
- 8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9. Bioprocessing Market Analysis - by Process

9.1 Overview
9.2 Downstream Bioprocess
- 9.2.1 Overview
- 9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
- 9.3.1 Overview
- 9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10. Bioprocessing Market Analysis - by Application

10.1 Overview
10.2 Monoclonal Antibodies
- 10.2.1 Overview
- 10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
- 10.3.1 Overview
- 10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
- 10.4.1 Overview
- 10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell and Gene Therapy
- 10.5.1 Overview
- 10.5.2 Cell and Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11. Bioprocessing Market Analysis - by End User

11.1 Overview
11.2 Biopharmaceutical Companies
- 11.2.1 Overview
- 11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
- 11.3.1 Overview
- 11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
- 11.4.1 Overview
- 11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12. Bioprocessing Market - Geographical Analysis

12.1 North America: Bioprocessing Market
- 12.1.1 Overview
- 12.1.2 North America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 12.1.2.1 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Product
    - 12.1.2.1.1 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Instruments
    - 12.1.2.1.1.1 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Bioreactors
    - 12.1.2.1.1.2 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Chromatography Systems
    - 12.1.2.1.2 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Consumables And Accessories
  - 12.1.2.2 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Scale Of Operation
  - 12.1.2.3 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Process
  - 12.1.2.4 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Application
  - 12.1.2.5 North America: Bioprocessing Market - Revenue and Forecast Analysis - by End User
- 12.1.3 North America: Bioprocessing Market - Revenue and Forecast Analysis - by Country
  - 12.1.3.1 United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.3.1.1 Overview
  - 12.1.3.2 United States: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.3.2.1 United States: Bioprocessing Market Breakdown, by Product
    - 12.1.3.2.1.1 United States: Bioprocessing Market Breakdown, by Instruments
    - 12.1.3.2.1.1.1 United States: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.3.2.1.1.2 United States: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.3.2.1.2 United States: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.1.3.2.2 United States: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.1.3.2.3 United States: Bioprocessing Market Breakdown, by Process
    - 12.1.3.2.4 United States: Bioprocessing Market Breakdown, by Application
    - 12.1.3.2.5 United States: Bioprocessing Market Breakdown, by End User
  - 12.1.3.3 Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.3.3.1 Overview
  - 12.1.3.4 Canada: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.3.4.1 Canada: Bioprocessing Market Breakdown, by Product
    - 12.1.3.4.1.1 Canada: Bioprocessing Market Breakdown, by Instruments
    - 12.1.3.4.1.1.1 Canada: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.3.4.1.1.2 Canada: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.3.4.1.2 Canada: Bioprocessing Market Breakdown, by Consumables and Accessories
    - 12.1.3.4.2 Canada: Bioprocessing Market Breakdown, by Scale of Operation
    - 12.1.3.4.3 Canada: Bioprocessing Market Breakdown, by Process
    - 12.1.3.4.4 Canada: Bioprocessing Market Breakdown, by Application
    - 12.1.3.4.5 Canada: Bioprocessing Market Breakdown, by End User
  - 12.1.3.5 Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.3.5.1 Overview
  - 12.1.3.6 Mexico: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.3.6.1 Mexico: Bioprocessing Market Breakdown, by Product
    - 12.1.3.6.1.1 Mexico: Bioprocessing Market Breakdown, by Instruments
    - 12.1.3.6.1.1.1 Mexico: Bioprocessing Market Breakdown, by Bioreactors
    - 12.1.3.6.1.1.2 Mexico: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.1.3.6.1.2 Mexico: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.1.3.6.2 Mexico: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.1.3.6.3 Mexico: Bioprocessing Market Breakdown, by Process
    - 12.1.3.6.4 Mexico: Bioprocessing Market Breakdown, by Application
    - 12.1.3.6.5 Mexico: Bioprocessing Market Breakdown, by End User
12.2 Europe: Bioprocessing Market
- 12.2.1 Overview
- 12.2.2 Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 12.2.2.1 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Product
    - 12.2.2.1.1 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Instruments
    - 12.2.2.1.1.1 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Bioreactors
    - 12.2.2.1.1.2 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Chromatography Systems
    - 12.2.2.1.2 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Consumables And Accessories
  - 12.2.2.2 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Scale Of Operation
  - 12.2.2.3 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Process
  - 12.2.2.4 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Application
  - 12.2.2.5 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by End User
- 12.2.3 Europe: Bioprocessing Market - Revenue and Forecast Analysis - by Country
  - 12.2.3.1 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.1.1 Overview
  - 12.2.3.2 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.2.1 Germany: Bioprocessing Market Breakdown, by Product
    - 12.2.3.2.1.1 Germany: Bioprocessing Market Breakdown, by Instruments
    - 12.2.3.2.1.1.1 Germany: Bioprocessing Market Breakdown, by Bioreactors
    - 12.2.3.2.1.1.2 Germany: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.2.3.2.1.2 Germany: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.2.3.2.2 Germany: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.2.3.2.3 Germany: Bioprocessing Market Breakdown, by Process
    - 12.2.3.2.4 Germany: Bioprocessing Market Breakdown, by Application
    - 12.2.3.2.5 Germany: Bioprocessing Market Breakdown, by End User
  - 12.2.3.3 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.3.1 Overview
  - 12.2.3.4 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.4.1 United Kingdom: Bioprocessing Market Breakdown, by Product
    - 12.2.3.4.1.1 United Kingdom: Bioprocessing Market Breakdown, by Instruments
    - 12.2.3.4.1.1.1 United Kingdom: Bioprocessing Market Breakdown, by Bioreactors
    - 12.2.3.4.1.1.2 United Kingdom: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.2.3.4.1.2 United Kingdom: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.2.3.4.2 United Kingdom: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.2.3.4.3 United Kingdom: Bioprocessing Market Breakdown, by Process
    - 12.2.3.4.4 United Kingdom: Bioprocessing Market Breakdown, by Application
    - 12.2.3.4.5 United Kingdom: Bioprocessing Market Breakdown, by End User
  - 12.2.3.5 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.5.1 Overview
  - 12.2.3.6 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.6.1 France: Bioprocessing Market Breakdown, by Product
    - 12.2.3.6.1.1 France: Bioprocessing Market Breakdown, by Instruments
    - 12.2.3.6.1.1.1 France: Bioprocessing Market Breakdown, by Bioreactors
    - 12.2.3.6.1.1.2 France: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.2.3.6.1.2 France: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.2.3.6.2 France: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.2.3.6.3 France: Bioprocessing Market Breakdown, by Process
    - 12.2.3.6.4 France: Bioprocessing Market Breakdown, by Application
    - 12.2.3.6.5 France: Bioprocessing Market Breakdown, by End User
  - 12.2.3.7 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.7.1 Overview
  - 12.2.3.8 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.8.1 Italy: Bioprocessing Market Breakdown, by Product
    - 12.2.3.8.1.1 Italy: Bioprocessing Market Breakdown, by Instruments
    - 12.2.3.8.1.1.1 Italy: Bioprocessing Market Breakdown, by Bioreactors
    - 12.2.3.8.2 Italy: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.2.3.8.2.1 Italy: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.2.3.8.3 Italy: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.2.3.8.4 Italy: Bioprocessing Market Breakdown, by Process
    - 12.2.3.8.5 Italy: Bioprocessing Market Breakdown, by Application
    - 12.2.3.8.6 Italy: Bioprocessing Market Breakdown, by End User
  - 12.2.3.9 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.9.1 Overview
  - 12.2.3.10 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.10.1 Spain: Bioprocessing Market Breakdown, by Product
    - 12.2.3.10.1.1 Spain: Bioprocessing Market Breakdown, by Instruments
    - 12.2.3.10.1.1.1 Spain: Bioprocessing Market Breakdown, by Bioreactors
    - 12.2.3.10.1.1.2 Spain: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.2.3.10.1.2 Spain: Bioprocessing Market Breakdown, by Consumables and Accessories
    - 12.2.3.10.2 Spain: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.2.3.10.3 Spain: Bioprocessing Market Breakdown, by Process
    - 12.2.3.10.4 Spain: Bioprocessing Market Breakdown, by Application
    - 12.2.3.10.5 Spain: Bioprocessing Market Breakdown, by End User
  - 12.2.3.11 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.11.1 Overview
  - 12.2.3.12 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.3.12.1 Rest of Europe: Bioprocessing Market Breakdown, by Product
    - 12.2.3.12.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Instruments
    - 12.2.3.12.1.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Bioreactors
    - 12.2.3.12.1.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.2.3.12.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Consumables and Accessories
    - 12.2.3.12.2 Rest of Europe: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.2.3.12.3 Rest of Europe: Bioprocessing Market Breakdown, by Process
    - 12.2.3.12.4 Rest of Europe: Bioprocessing Market Breakdown, by Application
    - 12.2.3.12.5 Rest of Europe: Bioprocessing Market Breakdown, by End User
12.3 Asia Pacific: Bioprocessing Market
- 12.3.1 Overview
- 12.3.2 Asia Pacific: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 12.3.2.1 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Product
    - 12.3.2.1.1 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Instruments
    - 12.3.2.1.1.1 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Bioreactors
    - 12.3.2.1.1.2 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Chromatography Systems
    - 12.3.2.1.2 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Consumables and Accessories
  - 12.3.2.2 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Scale of Operation
  - 12.3.2.3 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Process
  - 12.3.2.4 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Application
  - 12.3.2.5 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by End User
- 12.3.3 Asia Pacific: Bioprocessing Market - Revenue and Forecast Analysis - by Country
  - 12.3.3.1 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.1.1 Overview
  - 12.3.3.2 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.2.1 China: Bioprocessing Market Breakdown, by Product
    - 12.3.3.2.1.1 China: Bioprocessing Market Breakdown, by Instruments
    - 12.3.3.2.1.1.1 China: Bioprocessing Market Breakdown, by Bioreactors
    - 12.3.3.2.1.1.2 China: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.3.3.2.2 China: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.3.3.2.3 China: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.3.3.2.4 China: Bioprocessing Market Breakdown, by Process
    - 12.3.3.2.5 China: Bioprocessing Market Breakdown, by Application
    - 12.3.3.2.6 China: Bioprocessing Market Breakdown, by End User
  - 12.3.3.3 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.3.1 Overview
  - 12.3.3.4 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.4.1 India: Bioprocessing Market Breakdown, by Product
    - 12.3.3.4.1.1 India: Bioprocessing Market Breakdown, by Instruments
    - 12.3.3.4.1.1.1 India: Bioprocessing Market Breakdown, by Bioreactors
    - 12.3.3.4.1.1.2 India: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.3.3.4.1.2 India: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.3.3.4.2 India: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.3.3.4.3 India: Bioprocessing Market Breakdown, by Process
    - 12.3.3.4.4 India: Bioprocessing Market Breakdown, by Application
    - 12.3.3.4.5 India: Bioprocessing Market Breakdown, by End User
  - 12.3.3.5 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.5.1 Overview
  - 12.3.3.6 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.6.1 Japan: Bioprocessing Market Breakdown, by Product
    - 12.3.3.6.1.1 Japan: Bioprocessing Market Breakdown, by Instruments
    - 12.3.3.6.1.1.1 Japan: Bioprocessing Market Breakdown, by Bioreactors
    - 12.3.3.6.1.1.2 Japan: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.3.3.6.1.2 Japan: Bioprocessing Market Breakdown, by Consumables and Accessories
    - 12.3.3.6.2 Japan: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.3.3.6.3 Japan: Bioprocessing Market Breakdown, by Process
    - 12.3.3.6.4 Japan: Bioprocessing Market Breakdown, by Application
    - 12.3.3.6.5 Japan: Bioprocessing Market Breakdown, by End User
  - 12.3.3.7 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.7.1 Overview
  - 12.3.3.8 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.8.1 South Korea: Bioprocessing Market Breakdown, by Product
    - 12.3.3.8.1.1 South Korea: Bioprocessing Market Breakdown, by Instruments
    - 12.3.3.8.1.1.1 South Korea: Bioprocessing Market Breakdown, by Bioreactors
    - 12.3.3.8.1.1.2 South Korea: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.3.3.8.1.2 South Korea: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.3.3.8.2 South Korea: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.3.3.8.3 South Korea: Bioprocessing Market Breakdown, by Process
    - 12.3.3.8.4 South Korea: Bioprocessing Market Breakdown, by Application
    - 12.3.3.8.5 South Korea: Bioprocessing Market Breakdown, by End User
  - 12.3.3.9 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.9.1 Overview
  - 12.3.3.10 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.10.1 Australia: Bioprocessing Market Breakdown, by Product
    - 12.3.3.10.1.1 Australia: Bioprocessing Market Breakdown, by Instruments
    - 12.3.3.10.1.1.1 Australia: Bioprocessing Market Breakdown, by Bioreactors
    - 12.3.3.10.1.1.2 Australia: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.3.3.10.1.2 Australia: Bioprocessing Market Breakdown, by Consumables and Accessories
    - 12.3.3.10.2 Australia: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.3.3.10.3 Australia: Bioprocessing Market Breakdown, by Process
    - 12.3.3.10.4 Australia: Bioprocessing Market Breakdown, by Application
    - 12.3.3.10.5 Australia: Bioprocessing Market Breakdown, by End User
  - 12.3.3.11 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.11.1 Overview
  - 12.3.3.12 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.3.12.1 Rest of APAC: Bioprocessing Market Breakdown, by Product
    - 12.3.3.12.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Instruments
    - 12.3.3.12.1.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Bioreactors
    - 12.3.3.12.1.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.3.3.12.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.3.3.12.2 Rest of APAC: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.3.3.12.3 Rest of APAC: Bioprocessing Market Breakdown, by Process
    - 12.3.3.12.4 Rest of APAC: Bioprocessing Market Breakdown, by Application
    - 12.3.3.12.5 Rest of APAC: Bioprocessing Market Breakdown, by End User
12.4 Middle East & Africa: Bioprocessing Market
- 12.4.1 Overview
- 12.4.2 Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 12.4.2.1 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Product
    - 12.4.2.1.1 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Instruments
    - 12.4.2.1.1.1 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Bioreactors
    - 12.4.2.1.1.2 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Chromatography Systems
    - 12.4.2.1.2 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Consumables And Accessories
  - 12.4.2.2 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Scale Of Operation
  - 12.4.2.3 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Process
  - 12.4.2.4 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Application
  - 12.4.2.5 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by End User
- 12.4.3 Middle East & Africa: Bioprocessing Market - Revenue and Forecast Analysis - by Country
  - 12.4.3.1 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.1.1 Overview
  - 12.4.3.2 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.2.1 Saudi Arabia: Bioprocessing Market Breakdown, by Product
    - 12.4.3.2.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Instruments
    - 12.4.3.2.1.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Bioreactors
    - 12.4.3.2.1.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.4.3.2.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.4.3.2.2 Saudi Arabia: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.4.3.2.3 Saudi Arabia: Bioprocessing Market Breakdown, by Process
    - 12.4.3.2.4 Saudi Arabia: Bioprocessing Market Breakdown, by Application
    - 12.4.3.2.5 Saudi Arabia: Bioprocessing Market Breakdown, by End User
  - 12.4.3.3 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.3.1 Overview
  - 12.4.3.4 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.4.1 South Africa: Bioprocessing Market Breakdown, by Product
    - 12.4.3.4.1.1 South Africa: Bioprocessing Market Breakdown, by Instruments
    - 12.4.3.4.1.1.1 South Africa: Bioprocessing Market Breakdown, by Bioreactors
    - 12.4.3.4.1.1.2 South Africa: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.4.3.4.1.2 South Africa: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.4.3.4.2 South Africa: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.4.3.4.3 South Africa: Bioprocessing Market Breakdown, by Process
    - 12.4.3.4.4 South Africa: Bioprocessing Market Breakdown, by Application
    - 12.4.3.4.5 South Africa: Bioprocessing Market Breakdown, by End User
  - 12.4.3.5 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.5.1 Overview
  - 12.4.3.6 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.6.1 United Arab Emirates: Bioprocessing Market Breakdown, by Product
    - 12.4.3.6.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Instruments
    - 12.4.3.6.1.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Bioreactors
    - 12.4.3.6.1.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.4.3.6.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.4.3.6.2 United Arab Emirates: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.4.3.6.3 United Arab Emirates: Bioprocessing Market Breakdown, by Process
    - 12.4.3.6.4 United Arab Emirates: Bioprocessing Market Breakdown, by Application
    - 12.4.3.6.5 United Arab Emirates: Bioprocessing Market Breakdown, by End User
  - 12.4.3.7 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.7.1 Overview
  - 12.4.3.8 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.3.8.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Product
    - 12.4.3.8.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Instruments
    - 12.4.3.8.1.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Bioreactors
    - 12.4.3.8.1.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.4.3.8.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.4.3.8.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.4.3.8.3 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Process
    - 12.4.3.8.4 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Application
    - 12.4.3.8.5 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by End User
12.5 South & Central America: Bioprocessing Market
- 12.5.1 Overview
- 12.5.2 South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
  - 12.5.2.1 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Product
    - 12.5.2.1.1 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Instruments
    - 12.5.2.1.1.1 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Bioreactors
    - 12.5.2.1.1.2 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Chromatography Systems
    - 12.5.2.1.2 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Consumables And Accessories
  - 12.5.2.2 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Scale Of Operation
  - 12.5.2.3 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Process
  - 12.5.2.4 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Application
  - 12.5.2.5 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by End User
- 12.5.3 South & Central America: Bioprocessing Market - Revenue and Forecast Analysis - by Country
  - 12.5.3.1 Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.3.1.1 Overview
  - 12.5.3.2 Brazil: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.3.2.1 Brazil: Bioprocessing Market Breakdown, by Product
    - 12.5.3.2.1.1 Brazil: Bioprocessing Market Breakdown, by Instruments
    - 12.5.3.2.1.1.1 Brazil: Bioprocessing Market Breakdown, by Bioreactors
    - 12.5.3.2.1.1.2 Brazil: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.5.3.2.1.2 Brazil: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.5.3.2.2 Brazil: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.5.3.2.3 Brazil: Bioprocessing Market Breakdown, by Process
    - 12.5.3.2.4 Brazil: Bioprocessing Market Breakdown, by Application
    - 12.5.3.2.5 Brazil: Bioprocessing Market Breakdown, by End User
  - 12.5.3.3 Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.3.3.1 Overview
  - 12.5.3.4 Argentina: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.3.4.1 Argentina: Bioprocessing Market Breakdown, by Product
    - 12.5.3.4.1.1 Argentina: Bioprocessing Market Breakdown, by Instruments
    - 12.5.3.4.1.1.1 Argentina: Bioprocessing Market Breakdown, by Bioreactors
    - 12.5.3.4.1.1.2 Argentina: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.5.3.4.1.2 Argentina: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.5.3.4.2 Argentina: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.5.3.4.3 Argentina: Bioprocessing Market Breakdown, by Process
    - 12.5.3.4.4 Argentina: Bioprocessing Market Breakdown, by Application
    - 12.5.3.4.5 Argentina: Bioprocessing Market Breakdown, by End User
  - 12.5.3.5 Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.3.5.1 Overview
  - 12.5.3.6 Rest of South & Central America: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.3.6.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Product
    - 12.5.3.6.1.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Instruments
    - 12.5.3.6.1.1.1 Rest of South & Central America: Bioprocessing Market Breakdown, by Bioreactors
    - 12.5.3.6.1.1.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Chromatography Systems
    - 12.5.3.6.1.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Consumables And Accessories
    - 12.5.3.6.2 Rest of South & Central America: Bioprocessing Market Breakdown, by Scale Of Operation
    - 12.5.3.6.3 Rest of South & Central America: Bioprocessing Market Breakdown, by Process
    - 12.5.3.6.4 Rest of South & Central America: Bioprocessing Market Breakdown, by Application
    - 12.5.3.6.5 Rest of South & Central America: Bioprocessing Market Breakdown, by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Getinge AB
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Sartorius AG
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Corning Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Merck KGaA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 3M Co
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Eppendorf SE
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Repligen Corp
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Entegris Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Agilent Technologies Inc
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
14.12 Cytiva US LLC
- 14.12.1 Key Facts
- 14.12.2 Business Description
- 14.12.3 Products and Services
- 14.12.4 Financial Overview
- 14.12.5 SWOT Analysis
- 14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms